By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Leerink Swann downgraded Sigma-Aldrich to Market Perform from Outperform and reduced its target share price on the firm to a range of between $66 and $70. The bank lowered the EPS estimate for Sigma for full-year 2011 to $3.76 from $3.77. The lower estimates reflect a challenging academic funding environment as well as European macro-environment, an analyst said in a research note.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.